CTLA4 and autoimmune disease: In certain conditions, the administration of decoy coinhibitory receptors, such as CTLA-4 Ig or mAb, against coinhibitory molecules could inhibit the responses of self-reactive T cells in autoimmune disorders, thus suggesting that modulating the coinhibitory signals could be a promising approach to induce tolerance in autoimmune diseases [49].